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Abstract: 
Snakebites are a major neglected tropical disease responsible for as many as 95000 deaths every year worldwide. Viper venom 
serine proteases disrupt haemostasis of prey and victims by affecting various stages of the blood coagulation system. A better 
understanding of their sequence, structure, function and phylogenetic relationships will improve the knowledge on the 
pathological conditions and aid in the development of novel therapeutics for treating snakebites. A large dataset for all available 
viper venom serine proteases was developed and analysed to study various features of these enzymes. Despite the large number of 
venom serine protease sequences available, only a small proportion of these have been functionally characterised. Although, they 
share some of the common features such as a C-terminal extension, GWG motif and disulphide linkages, they vary widely between 
each other in features such as isoelectric points, potential N-glycosylation sites and functional characteristics. Some of the serine 
proteases contain substitutions for one or more of the critical residues in catalytic triad or primary specificity pockets. Phylogenetic 
analysis clustered all the sequences in three major groups. The sequences with substitutions in catalytic triad or specificity pocket 
clustered together in separate groups. Our study provides the most complete information on viper venom serine proteases to date 
and improves the current knowledge on the sequence, structure, function and phylogenetic relationships of these enzymes. This 
collective analysis of venom serine proteases will help in understanding the complexity of envenomation and potential therapeutic 
avenues. 
 
 
Background: 
Snakebite is a major neglected public health issue particularly 
among agricultural communities living in rural regions 
throughout the world [1, 2]. An estimated 2.5 million people are 
bitten by snakes each year and these are estimated to result in 
up to as high as 95000 deaths worldwide [2, 3]. Snake venoms 
are complex mixtures of enzymatic [4, 5] and non enzymatic 
proteins [6], together with other components such as 
carbohydrates, lipids, nucleosides and metals [4, 7]. Snake 
venom serine proteases are major components and have been 
identified mainly in the venoms of snakes belonging to the 
viperidae family with a few occurring in members of the 
elapidae, colubridae and hydrophidae families [8]. Many snake 
venom serine proteases exert their effects through the ability to 
disrupt the normal haemostasis of envenomed prey and victims 
[9]. Indeed, viper venom serine proteases (VVSPs) affect various 
stages of the blood coagulation system, activate platelets and 
directly act upon fibrinogen. These include pro-coagulant 
enzymes such as thrombin-like enzymes which clot fibrinogen 
(fibrinogenolytic), factor V activators, kininogenases and 
platelet aggregators, and anti-coagulant enzymes such as 
fibrinolytic enzymes, plasminogen activators and protein C 
activators [10].  
 
A detailed understanding of the components of snake venoms 
is important both for acquiring a more complete understanding 
of the pathology of envenomation and also to aid in the 
development of improved treatments for snakebites. Moreover, 
several venom enzymes, including VVSPs have proved to have 
potential as therapeutics for various human haemostatic 
disorders [11]. Despite their high sequence similarity, VVSPs 
differ widely in their functions. Accelerated evolution [12], exon 
switching [13] and point mutations [14] have been reported to 
be involved in the generation of novel VVSPs and adaption to 
different geographical locations and available prey. Due to their 
physiological and medical importance, understanding of VVSP 
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sequences, structures, functions and phylogenetic relationships 
represent research priorities. In this article, we report the 
collection of largest dataset of available VVSP sequences from 
public databases and literature and the detailed analysis of their 
sequence, structure, function and phylogenetic relationships. 
 
 
Figure 1: Number of VVSPs with different isoelectric points in 
each snake. The isoelectric point of all VVSPs was predicted and 
clustered together for every snake based on the number of 
VVSPs found with varying isoelectric points. Blue colour 
indicates the low number (0) and the red colour indicates 
highest number (17) of VVSPs. 
 
 
Figure 2: Number of VVSPs with different N-glycosylation sites 
in each snake. The potential N-glycosylation sites of all VVSPs 
were predicted and clustered together for every snake based on 
the number of VVSPs found with varying numbers of predicted 
sites. Blue colour indicates the low number (0) and the red 
colour indicates highest number (15) of VVSPs. 
Methodology: 
Collection of VVSP sequences  
Basic local alignment search tool (BLAST) [15] was used to 
search the NCBI protein database using several VVSP amino 
acid sequences. The NCBI and Swiss-Prot protein databases 
were searched with individual viper names and several 
keywords including serpentes, colubroidea, viperidae, 
viperinae and crotalinae to extract all VVSP sequences. Some 
published protein sequences, which had not been submitted to 
any of the sequence databases were collected directly from the 
literature. Several VVSP sequences were incomplete or 
contained internal deletions (longer than 10 amino acids), and 
were therefore excluded from our dataset. For each complete 
VVSP sequence the viper name, accession number, name (and 
alternative names if available) of the protein, experimentally 
determined functions and associated references were collected. 
Where two or more sequences had 100% sequence identity as 
determined by the EMBOSS pairwise alignment tool [16], 
duplicates were removed. Each sequence was allocated a 
reference code, determined using the viper’s scientific name 
followed by up to three letters representing the protein name 
(e.g. CDD-SP, where CDD represent the snake name, Crotalus 
durissus durissus and SP represent the protein name, serine 
protease). Where, the similar first letter of two or more species 
occurs within a genus, the second letter of species name was 
used in lower case (e.g. CAd-CR).  
 
Sequence analysis 
Multiple sequence alignment analysis of all the VVSP sequences 
was performed using the ClustalW2 multiple sequence 
alignment tool [17]. To aid comparison of the VVSP sequences 
with other serine proteases, the sequence of bovine α-
chymotrypsinogen (NCBI accession number: P00766) was 
included in the alignment. This enabled the commonly used 
chymotrypsinogen numbering pattern to be identified in the 
VVSP sequences. The alignment file was viewed using the 
Jalview-multiple sequence editor tool [18]. In some of the VVSP 
sequences (obtained from cDNA sequencing), the N-terminal 
signal and activation peptides were identified in comparison to 
previous literature and these were removed manually before 
the complete analysis. NetNGlyc tool was used to predict N-
glycosylation sites, and compute pI/MW tool from Expasy 
bioinformatics portal was used to predict the isoelectric points 
and molecular weight of VVSPs. The number of N-
glycosylation sites and isoelectric points of VVSPs in every 
snake were clustered using CIMminer software [19].  
 
Phylogenetic analysis 
To generate the phylogenetic tree, sequences were aligned 
using ClustalW within MEGA 4 [20] using a gap opening 
penalty of 10 and a gap extension penalty of 0.1 for the initial 
pairwise alignment and a gap opening penalty of 3 and gap 
extension penalty of 1.8 for the multiple alignment and the 
Gonnet protein weight matrix. The phylogenetic tree was 
generated within MEGA 4 using the neighbour-joining method 
and the Jones-Taylor-Thornton substitution model. The 
bootstrap test was performed using 2000 replications. The 
sequence of bovine α-chymotrypsinogen was used as an 
outgroup. 
 
Structural modeling 
Structural models of VVSPs were created using the IntFOLD 
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server [21]. Models were obtained for each sequence using the 
structure of rat trypsin (PDB code: 1co9) as a best matched 
template. Models were visualised and compared with each 
other and the structures of bovine α-chymotrpysin (PDB code: 
1YPH) and rat trypsin (PDB code: 1CO9) using PyMOL 
molecular graphics system, version 1.3 (DeLano Scientific). 
 
 
Figure 3: Structural models of VVSPs. Structural models of 
rhinocerases 2 (BG-RHIN2) and 4 (BG-RHIN4) were created 
using the IntFOLD server [17] using the structure of rat trypsin 
(PDB code: 1co9) as a template. (A) Schematic diagram showing 
the overall similarities in structure between BG-RHIN2 (yellow) 
and BG-RHIN4 (red). The side chain atom positions for the 
catalytic triad residues are included. (B) Detailed view of the 
amino acids corresponding to the catalytic triad residues in BG-
RHIN2 (yellow), BG-RHIN4 (red) and chymotrypsin (PDB code: 
1yph; cyan). BG-RHIN2 has substitutions for the serine and 
histidine residues. (C) Detailed view of the main constituents of 
the S1 specificity pocket in BG-RHIN2 (yellow), BG-RHIN4 
(red), chymotrypsin (cyan) and trypsin (pdb code: 1co9; green). 
In chymotrypsin these residues are: S189 at the base of the 
specificity pocket, with G216 and G226 at the sides. In trypsin 
D189 is at the base of the pocket, with G216 and G226. All 
images were generated using PyMOL. (D) Detailed view of the 
main constituents of the S1 specificity pocket in BG-RHIN2 
(green) and protein C activator (PDB code: 2AIQ; purple). 
 
Results and Discussion: 
Collection of VVSP sequences 
The collection of available VVSP sequences from the protein 
databases represented an initial step towards developing a 
comprehensive dataset of all VVSPs. BLAST was used to search 
the NCBI protein database using the amino acid sequences of 
several VVSPs in order to obtain all available sequences of 
VVSPs. In addition, the NCBI and Swiss-Prot databases were 
searched using list of viper names and several key words. There 
were several snake venom serine protease sequences from other 
than viperiade family members but since our main focus was on 
VVSPs, non-viper sequences were removed from the dataset. In 
total 196 complete sequences (after removing the duplicates and 
partial sequences) were obtained including 11 complete 
sequences extracted from relevant literature Table 1 (see 
supplementary material).  
 
Of the 196 available proteins only a small proportion (49 out of 
196 or 25%) of VVSPs has been experimentally characterised. 
Some (9) VVSPs have been shown to have more than one 
function and others have not been screened for more than one 
particular function of interest. Some VVSPs have been 
designated as thrombin-like enzymes or KN (which might 
mean kininogenase), but no information was available 
regarding the basis of this classification. For several available 
VVSP sequences, associated published article or information 
regarding respective functions and other characteristics were 
not available. Structural information for the VVSPs is currently 
limited with structures solved for only 5 (2.6% in total) VVSPs 
known. 
 
Our comprehensive dataset of VVSPs has been acquired using 
semi-automated methods and to our knowledge, this is the 
most complete collection to date of VVSP sequences. The 
absence of some sequences from any of the sequence databases 
makes it impossible to acquire this completely automatically. 
The use of different naming conventions by various authors 
also makes it difficult to obtain the VVSP sequences using 
keyword searches. The VVSP sequences along with other serine 
protease sequences from reptiles (other than viper snakes and 
lizards) grouped together in BLAST analysis, indicating them to 
have higher sequence similarities to each other than to non-
reptile serine proteases.  
 
General characteristics of VVSP sequences 
To analyse the various features of VVSPs, all sequences were 
aligned together along with bovine α-chymotrypsinogen. Initial 
multiple sequence alignments of VVSPs demonstrated that 
many sequences occurred in precursor form, containing signal 
(18 amino acids) and activation peptides (6 amino acids) at the 
N-terminus. These were removed from all VVSP sequences and 
only the mature protein sequences were aligned for sequence 
analysis (Figure S1- this figure is available from authors). The 
bovine α-chymotrypsinogen-based sequence numbering was 
used throughout the study to allow easier discussion with non-
VVSP sequences.  
 
Activation of VVSPs 
Most of eukaryotic proteases (e.g. digestive enzymes) are 
synthesised as precursors and become mature enzymes at their 
target sites following the cleavage of signal/activation peptides. 
As snake venoms are synthesised from the venom glands and 
the venom facilitates the immobilization and digestion of prey, 
they are also synthesised as inactive zymogens with signal and 
activation peptides [12]. These signal and activation peptides 
are only present in the sequences which were obtained through 
cDNA sequencing and were absent in any of the VVSP 
sequences obtained through Edman N-terminus sequencing 
methods from the purified proteins. A previous study [21] 
reported that venom proteins are stored at an acidic pH in the 
lumen of main secretary gland where they are maintained in 
their zymogen state to prevent unwanted proteolytic activity in 
the venom gland. During venom extraction or a bite, the venom 
flows through the rostral portion of accessory gland which is 
rich in serous secretions (contain proteolytic enzymes) that 
result in activation of proteolytic enzymes [22]. 
Isoelectric point of VVSPs 
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The isoelectric point of each VVSP sequence was predicted in 
order to analyse the distribution of VVSPs with varying 
characteristics within and among other snake venoms. The 
predicted isoelectric point of each VVSP varies between 4.6 and 
9.4 (Figure 1). Depending upon the number of VVSP sequences 
known in each venom, the distribution of VVSPs vary. The 
majority of VVSPs present in all the snake venoms analysed lie 
between isoelectric points of 5 and 7 or 8 and 9. This analysis 
indicates that snakes produce a mixture of serine proteases with 
varying isoelectric points and these may result in alteration of 
their functional properties to adapt various substrates in 
diverse preys. 
 
N-glycosylation sites in VVSPs 
Since glycosylation in two of the VVSPs (DA-ASI and DA-ASII) 
has been demonstrated to affect the substrate specificity of these 
enzymes [23], the potential N-glycosylation sites were predicted 
for all VVSP sequences. The number of predicted N-
glycosylation sites in VVSPs varies between 0 and 6 (Figure 2). 
This analysis indicates that although some (16) of VVSPs are not 
glycosylated, many of the VVSPs have one (68) or more (112) 
potential glycosylation sites. Glycosylation of VVSPs may 
represent a general feature that contributes to the determination 
of substrate specificity similar to DA-ASI and DA-ASII. 
Moreover, the addition of glycosylation moieties will increase 
the molecular weights of native VVSPs in actual venom. The 
difference in molecular weights of VVSP homologs in different 
species is well reported in literature [14].    
  
GWG motif  
The conversion of inactive zymogens into active enzymes is a 
key step to initiate the activity of several digestive and clotting 
enzymes at their target sites. This conversion is usually takes 
place by proteolytic cleavage at specific sites and by altering the 
structural fold of active enzymes. Fehlhammer et al. [24] 
reported that a GWG motif between residues 140 and 142 in 
chymotrypsinogen was an important site for the conversion of a 
flexible zymogen structure into a fixed rigid orientation in the 
activated chymotrypsin. This motif is absolutely conserved in 
all VVSPs analysed (Figure S1), suggesting that it may play 
roles in the conversion of inactive to active VVSPs. 
 
C-terminal extension 
The sequence alignment shows that the length of most of the 
mature VVSPs is between 228 and 239 amino acid residues. 
Compared to chymotrypsinogen, all the VVSPs lack 15 amino 
acids at the N-terminus of the mature proteins which indicates 
the removal of signal and activation peptides. While most (179) 
of the VVSPs contain a C-terminal extension of 7 amino acids, 
some (17) contain smaller or larger extension (Figure S1). This 
C-terminus feature is not present in chymotrypsin, trypsin, 
thrombin and other known mammalian serine proteases, 
suggesting this to be a unique feature of VVSPs. This C-terminal 
extension contains a cysteine residue which may form a 
disulphide linkage with C91 in all the VVSPs to offer additional 
stability for maintaining their structures as determined for VS-
VPA [25].   
 
Stability of VVSPs 
Salt bridge 
Salt bridges are usually formed between an acidic and a basic 
residue to stabilise the structure. A common salt bridge in 
trypsin and VVSPs was reported between the residues V/I16 
and D194 [25, 26]. This is formed after the activation of the 
enzyme from its precursor form and is involved in stabilisation 
of the active site structure. All VVSPs have either valine or 
isoleucine at position 16 (except one VVSP, EP-SP1 which has a 
deletion at this position) and aspartate at position 194 (except 
VS-KN10 which has valine at this position) (Figure S1). Thus 
with the exception of these two VVSPs, all others are likely to 
form a salt bridge between the residues in these positions in 
order to increase the stability of the enzymes. 
 
Disulphide linkages 
The trypsin-like serine proteases contain 10 cysteine residues 
which normally form 5 disulphide linkages. But in the 
experimentally analysed VVSPs 12 cysteine residues are found, 
and in the structure of VS-VPA they have been shown to form 6 
disulphide linkages [25]. These are C22-C157, C42-C58, C91-
C245e, C136-C201, C168-C182 and C191-C220. It is likely that 
similar disulphide bonds may form in all other VVSPs where 
these cysteine residues present at corresponding position. The 
disulphide linkage C91-C245e is a unique characteristic to 
VVSPs [25]. In VVSP sequence alignment (Figure S1), although 
7 of the cysteine residues [C22, C136, C157, C168, C182, C191 
and C220] are absolutely conserved in all VVSPs, 13 VVSPs 
have substitutions for one of the other 5 cysteine residues (Table 
2). C42 is substituted in 4 VVSPs (CC-CR, VS-KN5, VS-KN6 and 
VS-KN14); C58 is substituted in one (DA-TL4); C91 is present in 
all VVSPs except for two (BAI-BH and GBB-SL); C245e was 
substituted in three VVSPs, EO-SP2, CAd-SP5 and EC-SP6, and 
a deletion was found in EO-SP5 at this position. C201 was 
substituted in two VVSPs, DA-DK and DA-TL7. In some 
VVSPs, the C91 has been aligned at the positions of 90 or 92, but 
these form disulphide linkages as normal in modelled 
structures (data not shown). This analysis shows that in some of 
the VVSPs, specific disulphide linkages cannot be formed due 
to the substitutions. It is entirely not clear how these 
substitutions and subsequent loss of corresponding disulphide 
linkages would affect the architecture of the VVSP structures 
and their function. GBB-SL which lacks C91-C245e, however, 
has been functionally characterised to have α and β 
fibrinogenolytic activities [information obtained from the NCBI 
protein database].  
 
Functional characteristics of VVSPs 
Catalytic triad 
Trypsin-like serine proteases share a catalytic triad which 
includes H57, D102 and S195 (bovine α-chymotrypsinogen 
numbering)  [25]. These residues are conserved in majority of 
the VVSPs (Figure S1) and so they would be expected to be 
catalytically active. 21 VVSPs have substitutions for one or two 
of the catalytic triad residues. Substitutions to the catalytic triad 
residues have previously been observed in a small number of 
VVSPs [12, 14, 27, 28]. The majority of these sequences have 
been identified at transcript level only; prior to this study only 
four serine proteases (BG-RHIN2 & 3, BAI-BH and TJ-SPH) 
with catalytic triad substitutions have been identified within the 
venom of snakes [14, 28, 29]. Functional analysis of one of these 
proteins (TJ-SPH) has confirmed this to be functionally inactive 
[28], but, interestingly, another VVSP, bhalternin (BAI-BH) with 
substitutions at positions 57 (N) and 102 (T) has been shown to 
be functionally active [29]. It is therefore hard to conclude if 
these VVSPs would be functionally active or inactive with 
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substitutions within the catalytic triad. The serine proteases 
with catalytic triad substitutions are commonly called serine 
protease homologues [28]. Table 3 (see supplementary 
material) shows the VVSPs with catalytic triad substitutions. 
The most frequently substituted residue within the catalytic 
triad is H57, which has been substituted by R in 15 sequences, 
by N in 3 sequences and by Q in one sequence. Ten of the 
sequences have substitutions for the catalytic S195; in five 
VVSPs this has been substituted by N, one protein has a S195P 
substitution, three have a S195T substitution and one has 
alanine at this position. In contrast, D102 is conserved in all the 
sequences except one, BAI-BH which has threonine at this 
position.  
 
Structural models of these VVSPs show that they are generally 
similar to each other, consistent with the sequence similarity of 
the enzymes, but they differ at their catalytic site. For example, 
rhinocerases, BG-RHIN2 and 3 contain catalytic triad 
substitutions at positions 57 and 195, but show overall 
similarity to the predicted structures of other rhinocerases, BG-
RHIN4 and 5 which contain normal catalytic triad (Figure 3A). 
They show differences at their catalytic site (Figure 3B). D102 is 
at almost identical positions in rhinocerases 2 and 4, and bovine 
chymotrypsin. The catalytic serine is at a very similar position 
in rhinocerase 4 and chymotrypsin, and the substituted N in 
BG-RHIN2 is also similarly located. However the substitution 
of the long arginine side chain instead of histidine at position 57 
in BG-RHIN2 has resulted in a significant change to the 
orientation of the side chain in the modelled structure (Figure 
3B). Similarly other VVSPs with different amino acid 
substitutions show differences in their catalytic sites. 
 
Proteins with substitutions to the catalytic triad are present in 
many enzyme families; indeed it has been estimated that up to 
15% of the members of all encoded enzyme families may have 
lost their catalytic activity [30]. Siigur et al. [12] suggested that 
the critical substitutions in the VVSP, ML-P2 from the venom of 
Macrovipera lebetina could be generated via trans-splicing of the 
primary gene transcript, exon-shuffling or unequal crossing 
over at the genome level. We have however, shown previously 
that these substitutions may have occurred at multiple levels 
[14]. Although one of the VVSPs with a catalytic triad 
substitution was proved to be functionally active [29], another 
was shown to be inactive [28]. No further VVSP of this nature 
has been functionally characterised. So it is not entirely clear if 
these proteins are functionally active in the venom. In many 
cases in other biological systems, inactive homologues are 
believed to have acquired alternative functions, such as 
competing with and antagonising the active proteases, or 
otherwise regulating their function. Within invertebrates, serine 
protease homologues have  been shown to be involved in 
various defence responses [31]. It has however, been suggested 
that some invertebrate serine protease homologues are unlikely 
to bind peptide substrates by a canonical protease-like 
mechanism, though other potential protein binding sites have 
been suggested [32]. Within snake venom, catalytically inactive 
phospholipase A2 such as myotoxins II and IV from the venom 
of Bothrops asper are known to act as toxins and are thought to 
bind to their target membrane substrates in order to reduce 
their permeability control and cause subsequent necrosis [33]. 
Corey et al. [34] reported that trypsin with a H57R substitution 
had 190000 fold lower activities than the wild type enzyme at 
pH 8.0 but had 38 fold higher activities than the wild type at pH 
10.1. Clearly, experiments to determine the function of the 
serine protease homologues within snake venom need to be 
performed. It is possible that they may affect the physiology of 
victims or prey by binding irreversibly to substrates involved in 
blood coagulation and preventing their normal function.  
 
Specificity of VVSPs 
The primary specificity pocket of serine proteases (also called as 
S1 binding site) accommodates the side chain of the P1 residue 
(the residue preceding the scissile bond) of substrates and 
confer specificity towards substrates. For example, 
chymotrypsin contains S189, G216 and G226 and is specific for 
the large hydrophobic side chains (such as F, Y and W) [35]. 
Trypsin and thrombin contain D189, G216 and G226 and are 
specific for positively charged amino acids such as R and K [35]. 
Elastase contains S189, V216 and T226 and is specific for small 
hydrophobic side chains like alanine [35]. In addition to the 
catalytic triad residues, there are also differences found in the 
residues present in the primary specificity pockets of several 
VVSPs (Figure S1). In total 161 VVSPs have D189, G216 and 
G/A226 and so they may confer specificity towards either or 
both positively charged amino acids such as R and K at P1 
position of substrates similar to trypsin and thrombin.  
 
The remaining 35 VVSPs, however, have different combinations 
of specificity pocket residues Table 4 (see supplementary 
material). Although seven VVSPs contain aspartate at 
position189, they have substitutions in the other two sites and 
thus, they might restrict entry for substrates. For example, in 
the venom of Bitis gabonica rhinoceros, BG-RHIN2 and 3 have 
D189, which might indicate specificity for basic residues but 
have E instead of G at position 216 and A instead of G at 
position 226 (Figure 3C & 3D). These substitutions are likely to 
restrict access to the specificity pocket, thus the binding 
specificity of BG-RHIN2 and 3 is not clear. In contrast, two 
other VVSPs (BJa-HP3 and AP-PA), contain D189-R216-G226 in 
their specificity pocket. So the presence of arginine at position 
216 may create a basic environment in the pocket. The functions 
of these VVSPs are further critical as they contain D at 189 and 
R at 216. A further two VVSPs (TG-SP3 and VS-KN8) contain 
D189-G216-N/V226 in their specificity pocket. Although they 
can confer specificity towards basic amino acids in their 
substrates, the presence of N or V at position 226 will have 
influence in their specificity.   
 
The remaining 28 VVSPs contain substitution mainly for 
position 189 Table 4 (see supplementary material). Thus, these 
enzymes may not confer specificity for arginine at P1 position 
of the substrates. For example, 13 VVSPs have G189-G216-G226 
in their specificity pocket. This is an unusual substitution in 
trypsin-like serine proteases, which is similar to the human 
kallikrein KLK9 whose specificity is unknown [36]. The 
substitution might be expected to increase the size of the 
specificity pocket; M. lebetina α and β-fibrinogenases (ML-AF 
and ML-BF) also have G189 [37] and Siigur et al. [38] have 
reported that ML-AF hydrolysed the Y16 – L17, F24 – F25 and 
F25 – Y26 bonds of the insulin B chain, suggesting that enzymes 
with G189 can cleave substrates with large hydrophobic 
residues at the P1 position. Some VVSPs such as BG-RHIN4 and 
5 also have a G to A substitution at position 216 which may 
narrow the specificity pocket slightly. There are also other 
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combinations of residues present in small number of VVSPs 
whose functions are unknown.   
 
Comparison of the positions and orientations of residues in the 
S1 specificity pockets of BG-RHIN2 and 4 with those of 
chymotrypsin and trypsin suggest that, the bottom of the 
specificity pocket is very similar in BG-RHIN2 and trypsin, 
while the glycine in BG-RHIN4 is uncharged and protrudes 
even less into the pocket (Figure 3C). At position 226, the 
glycines and alanines in all enzymes are very similarly located. 
In contrast, the substitution of the large negatively charged 
glutamic acid at position 216 clearly has a significant effect on 
the S1 pocket in BG-RHIN2 when the modelled structure was 
compared to model of BG-RHIN4 (Figure 3C). When BG-
RHIN2 model was superimposed on the determined structure 
of protein C activator (AC-AN) [39], G217 of BG-RHIN2 is 
situated at the same position as G216 of AC-AN (Figure 3D). So 
it is not entirely clear if negatively charged glutamate or glycine 
would occupy this position in the real structure of BG-RHIN2. 
However the primary specificity pocket is not the sole 
determinant of specificity. For serine proteases involved in 
coagulation, the importance of additional regions of the 
structure e.g. exosites in recognition of substrates is becoming 
increasingly recognised [40]. Thus the precise specificity of 
these enzymes can only be determined experimentally. The 
potential role of exosites in binding to substrates also 
strengthens our suggestion above that the serine proteases 
homologues which lack the catalytic triad may still be capable 
of interfering with the coagulation cascade through exosite-
mediated interactions.   
 
Oxyanion hole 
A further interesting feature of VVSP sequences is that G193, 
which is generally highly conserved in serine proteases and is 
involved in the formation of oxyanion hole and in inhibitor 
binding [41], is substituted in 57 sequences: R in 25, A in 7, V in 
6, F in 6, Q in 4, H in 3, C in 2, Y in 2, S in 1 and T in 1 VVSP 
(Figure S1). As for VS-VPA, a venom plasminogen activator 
from Trimeresurus stejnegeri, which has F at position 193 [41], 
bulky residues substituted for G193 may reduce the sensitivity 
of the proteins to inhibitors such as bovine pancreatic trypsin 
inhibitor as well as reduce their interaction with substrates. 
Similarly other residues including charged residues such as 
arginine and glutamine may influence the formation of 
oxyanion hole and inhibitor or substrate binding.  
 
RGD motif 
The arginine-glycine-aspartate (RGD) motif acts as a cell 
adhesion signal and is present in cellular signal transduction 
proteins. It has also been reported that proteins containing RGD 
motifs may induce apoptosis [42]. Lee et al. [43] identified a 
RGD motif in brevinase (GB-BV) and suggested that it might be 
involved in cellular recognition and in inhibition of platelet 
aggregation through binding to integrin αIIbβ3. In our analysis 
we have identified the RGD motif at the same position as GB-
BV (between 192 and 194), in four other VVSPs: GB-HY, GH-H, 
GU-TC and GSh-SH (Figure S1). VVSPs containing the RGD 
motif could be involved in inducing cell death in order to cause 
destruction of cells in the host system. They may also inhibit 
platelet aggregation. As RGD motifs were found only in VVSPs 
from venoms of the Gloydius genus so far, this may be a unique 
feature of these snake venoms. 
Phylogenetic analysis of VVSPs 
Phylogenetic analysis was performed to analyse the 
evolutionary and functional relationships of VVSP sequences. 
The phylogenetic tree generated for 196 VVSP sequences is 
shown in (Figure 4). The sequence of bovine α-
chymotrypsinogen was displayed as an out-group in the tree. 
Wang et al. [44] generated a phylogenetic tree with 41 VVSP 
sequences using the Phylip-neighbor method. From their tree, 
three categories of VVSPs were identified, which they named 
kininogenases (KN), clotting enzymes (CL) and plasminogen 
activators (PA). These names described the known functions of 
some members of each of the categories. They also suggested 
that the KN category might be divided into 2 subcategories, 
with one representing GBH and another representing PMM1-
PMM5 and that this division might become more apparent if 
more sequences, particularly from true vipers were added. This 
classification was not apparent in our analysis with 196 
sequences, which cluster together in 3 major groups (named I, II 
and III).     
 
The sequences from true vipers (viperinae subfamily) are 
mostly clustered together in group II and III (shown as red 
letters in Figure 4). Moreover, the VVSPs with catalytic triad 
substitutions (shown as # in the Figure 4) cluster together in 
group III accept two VVSPs which cluster in I and II. Similarly, 
the sequences with substituted primary specificity pocket are 
clustered in groups I and II, with an exception of one VVSP 
which cluster in group III (shown as * in the Figure 4). This 
suggests that the VVSPs from true vipers differ evolutionarily 
from the pit vipers. Moreover, the evolution of VVSPs with 
substitutions in the catalytic triad and specificity pocket is not a 
random process in any particular snake; instead it might be a 
controlled mechanism to develop novel VVSPs with differing 
characteristic features.  
 
The experimentally determined functions of some VVSPs are 
indicated (as green letters in Figure 4) in the tree. Since majority 
of the functionally characterised VVSPs are capable of 
performing more than one function, the classification of VVSPs 
based on their function is difficult. Moreover, several VVSPs 
have been characterised only for the functions of interest and 
thus, they were not screened for other functions which they 
may perform. This analysis indicates that the classification of 
VVSPs based on some of the functionally characterised VVSPs 
as previously reported [44], may not appropriate with all the 
available VVSPs. For example, the VVSPs with kininogenase 
activities are clustered in all three groups in the tree. Similarly 
the coagulant enzymes such as α-fibrinogenase (AF), β-
fibrinogenase (BF) and αβ-fibrinogenase (ABF) are present 
randomly in all clusters. Some enzymes such as plasminogen or 
factor V activators are clustered together in a particular group 
in the tree, although only a very small number of VVSPs with 
those functions are identified to date. Moreover, the number of 
VVSPs performing additional functions such as platelet 
aggregator, factor VIII/X/XIII activator, an enzyme increases 
capillary permeability and albuminolytic/ myonecrotic/ 
heamolytic enzymes are limited and thus it is not apparent to 
predict the functions of other VVSPs which cluster together 
with these enzymes. 
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Figure 4: Phylogenetic tree of VVSPs. 196 VVSPs sequences 
from were included for the generation of a phylogenetic tree 
together with bovine α-chymotrypsinogen (NCBI accession 
number: P00766) as an out-group. The alignment was generated 
using ClustalW within MEGA 4 using a gap opening penalty of 
10 and a gap extension penalty of 0.1 for the initial pairwise 
alignment, gap opening penalty of 3 and gap extension penalty 
of 1.8 for the multiple alignment and the Gonnet protein weight 
matrix. The phylogenetic tree was generated from this within 
MEGA 4 using the neighbour-joining method and the Jones-
Taylor-Thornton substitution model. The bootstrap test was 
done using 2000 replications. The VVSPs from true vipers 
(viperinae sub family) are shown in red. # and* indicate the 
sequences with catalytic triad and specificity pocket 
substitutions respectively. The experimentally determined 
functions of VVSPs are shown in green letters with short codes; 
AF- α fibrinogenase, BF- β fibrinogenase, ABF- αβ 
fibrinogenase, KN- kininogenase, CPI- capillary permeability 
increasing enzyme, FVA- factor V activator, FXIIIA- factor XIII 
activator, CE- clotting enzyme, PA- plasminogen activator, 
PLA- platelet activator, ABGF- αβγ fibrinogenase, PTA- 
prothrombin activator, FXA- factor X activator, FVIIIA- factor 
VIII activator, FVIIA- factor VII activator, PCA- protein C 
activator, FIXA- factor IX activator and HL- haemolytic enzyme 
 
Conclusion: 
To our knowledge this study represents the most complete 
information about VVSPs available to date and this will serve as 
a dataset for further analysis in these enzymes. VVSPs share 
several sequence features such as catalytic triad and disulphide 
linkages with other common serine proteases for example, 
chymotrypsin, trypsin and thrombin. Some features, such as the 
C-terminal extension of 7 residues and an additional disulphide 
linkage, are unique to VVSPs. However, within the VVSP 
family there are many sequence variations which might be 
responsible for the variation in specificity of these enzymes. The 
phylogenetic analysis of VVSPs shows three clusters of 
sequences and the classification of these enzymes based on only 
a few functionally characterised enzymes may not be 
appropriate with a larger dataset. Our analysis showed that the 
naming or prediction of function for each cluster may not be 
possible as previously suggested when we include more 
sequences as most of them are of unknown functions and some 
of them are only partially characterised. A greater level of 
functional characterisation is needed to obtain more complete 
functionally known VVSPs for better understanding of their 
sequence, function and evolutionary relationships. 
Posttranslational modification predictions showed that most of 
the VVSPs were predicted to be N-glycosylated. The functions 
of these modifications in VVSPs are yet to be clearly identified 
but, in several other proteins it has been shown that 
glycosylation affects the function of the protein. Structural 
analysis of VVSPs has helped to identify the functionally 
important residues; catalytic triad, primary specificity pocket 
and disulphide linkages. However only 5 determined structures 
of VVSPs are available to date and thus more crystallisation 
work should be performed to obtain more structures. The 
dataset presented here with complete information of all known 
VVSPs to date will form a basis for further research to explore 
more about the sequence, structure, function and phylogenetic 
relationships of these enzymes in order to develop improved 
therapeutics for the treatment of snakebites. 
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Supplementary material: 
 
Table 1: The dataset of VVSPs used in the analysis. In total 185 VVSP sequences were collected from the protein sequence databases and 11 sequences were obtained 
from relevant literature (indicated as ‘not reported’ under accession number category). The name of snake, NCBI accession number and the short reference code for each 
sequence is given in the table 
Viper Species Accession number Reference code Viper Species Accession number Reference code 
Agkistrodon bileatus Q9PSN3 AB-BL  ADI47557 EP-SP2 
Agkistrodon contortrix contortrix P82981 AC-CN Gloydius blomhoffi P81176 GB-HY 
 P09872 AC-AN  Q9PT51 GB-BV 
Agkistrodon piscivorus leucostoma ADP88562 AP-PC Gloydius blomhoffi brevicaudus AAD01624 GBB-PA 
 ADP88561 AP-PA  Q9YGJ9 GBB-H2 
 ADW77220 AP-TL  P85109 GBB-KA 
Bitis gabonica rhinoceros AAR24534 BG-SP1  Q9PTL3 GBB-SL 
 CBM40645 BG-RHIN2 Gloydius halys Q9YGI6 GH-P2 
 CBM40646 BG-RHIN3  O93421 GH-PS 
 CBM40647 BG-RHIN4  Q802F0 GH-PT 
 CBM40648 BG-RHIN5 Gloydius halys Q9YGJ2 GH-PL 
Bothrops alternatus Q6IWF1 BAl-BT  AAC61838 GH-SL 
 P0CG03 BAl-BH  P81176 GH-H 
Bothrops asper Q072L6 BAs-SPL Gloydius saxatilis Q7SZE1 GSa-DE 
Bothrops atrox P04971 BAt-BT Gloydius shedaoensis Q6T5L0 GSh-SH 
 AAA48553 BAt-BAT  P0C5B4 GSh-GL 
Bothrops insularis Q8QG86 BI-SP Gloydius ussuriensis Q7SZE2 GU-BRE 
Bothrops jararaca Q5W959 BJa-HP2  Q8UUJ2 GU-TUI 
 P81824 BJa-PABJ  Q91053 GU-TC 
 O13069 BJa-KN  Q8UUJ1 GU-TUA 
 Q9PTU8 BJa-SPA  O42207 GU-CPI 
 P81661 BJa-BT  Q8UVX1 GU-TG 
 Q5W960 BJa-HP1  P86171 GU-KR 
 Q5W958 BJa-HP3  Not reported GU-GS 
Bothrops jararacussu Q2PQJ3 BJu-SP1 Lachesis muta muta Q27J47 LMM-PA 
 Q7T229 Bju-SPH  P33589 LMM-GY 
Calloselasma rhodostoma P26324 CR-AN Lachesis stenophrys Q072L7 LS-TLE 
 P47797 CR-A Macrovipera lebetina Q9PT41 ML-FVA 
 CAA01526 CR-ALP4  Q9PT40 ML-P2 
 CAA01525 CR-ALP1  Q8JH85 ML-AF 
 CAA01524 CR-ALP2  Q8JH62 ML-BF 
 CAA01523 CR-ALP3  Not reported ML-P3 
Cerastes cerastes Q7SYF1 CC-CR  Not reported ML-P4 
Crotalus adamanteus Q8UUK2 CAd-SP  ADN04917 ML-BFP 
 Not reported CAd-CR  ADN04916 ML-SP1 
 AEJ32000 CAd-SP6  ADN04918 ML-SP3 
 AEJ31999 CAd-SP5 Protobothrops mucrosquamatus Q9DG84 PM-S2 
 AEJ31998 CAd-SP4  Q91511 PM-M5 
 AEJ31997 CAd-SP3  Q91507 PM-M1 
 AEJ31996 CAd-SP2  Q91510 PM-M4 
 AEJ31995 CAd-SP1  AAB01070 PM-PT 
Crotalus atrox Q8QHK2 CAt-CT2  Q9DG83 PM-SK 
 Q8QHK3 CAt-CT1  Q91509 PM-M3 
Crotalus durissus terrificus Q58G94 CDT-G21  Q91508 PM-M2 
 ABY65929 CDT-G13 Sistrurus catenatus edwardsi ABG26969 SCE-SP3 
 ABY65930 CDT-G14  ABG26970 SCE-SP4 
 ABY65931 CDT-G17  ABG26974 SCE-SP8 
Crotalus durissus durissus Q2QA04 CDD-SP  ABG26975 SCE-SP9 
Cryptelytrops albolabris Not reported CAl-AF  ABG26967 SCE-SP1 
 Not reported CAl-PA  ABG26977 SCE-SP11 
 ABS12074 CAl-TL1  ABG26968 SCE-SP2 
 ABS12075 CAl-TL2  ABG26972 SCE-SP6 
Daboia russelli siamensis P18965 DR-VG  ABG26976 SCE-SP10 
 P18964 DR-VA  ABG26973 SCE-SP7 
 ADP88560 DR-SB  ABG26971 SCE-SP5 
 ADP88559 DR-SA Protobothrops elegans Not reported PE-PI 
 ADP88558 DR-VGP  P84787 PE-EL2 
 3SBK_A DR-VS  P84788 PE-EL1 
Deinagkistrodon acutus AAW56608 DA-TL1 Trimeresurus flavoviridis P05620 TF-TLE 
 AAW56633 DA-TL2  1405260A TF-FL 
 AAW56609 DA-TL3  O13057 TF-SP2 
 ABK91854 DA-TL4  O13058 TF-SP3 
 ABK91856 DA-TL5 Trimeresurus gramineus O13059 TG-SP1 
 ABK97625 DA-TL6  O13062 TG-SP2C 
 ABK97628 DA-TL7  O13063 TG-SP3 
 ABK91852 DA-TL8  O13060 TG-SP2A 
 AAK52506 DA-TL10  O13061 TG-SP2B 
 ABK97627 DA-TL11 Trimeresurus jerdonii Q9DF66 TJ-SP3 
 ABK91853 DA-TL12  Q9DF67 TJ-SP2 
 ABK97626 DA-TL13  Q9DF68 TJ-SP1 
 1OP2_A DA-ASII  B0ZT25 TJ-SPH 
 1OP0_A DA-ASI Viridovipera stejnegeri Q8AY79 VS-S2 
 AAD19350 DA-DF  Q71QH7 VS-PA 
 Q9I8X0 DA-DK  1BQY_A VS-VPA 
 Q9I8W9 DA-DX  Q8AY82 VS-SPH1 
 CAC00530 DA-AC2  Q71QJ1 VS-KN9 
 CAB46431 DA-AC  Q71QI8 VS-KN10 
 Q9I8X2 DA-AT  Q71QJ3 VS-KN1 
 ACF17164 DA-VY  Q71QH5 VS-KN8 
 Not reported DA-P1  Q71QI5 VS-KN3 
 Not reported DA-P7  Q71QI7 VS-KN11 
 Not reported DA-P8  Q71QI4 VS-KN5 
 Not reported DA-P9  Q71QJ4 VS-KNH4 
 ABV89584 DA-TL  Q71QI1 VS-KN12 
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Echis coloratus ADI47576 EC-SP1  Q71QH6 VS-KN13 
 ADI47574 EC-SP2  Q8AY80 VS-S1 
 ADI47566 EC-SP3  Q8AY78 VS-SP5 
 ADI47562 EC-SP4  Q8AY81 VS-SJ 
 ADI47559 EC-SP5  AAQ02901 VS-C3 
 ADI47552 EC-SP6  AAQ02898 VS-C1 
 ADI47549 EC-SP7  Q71QI3 VS-C5 
Echis ocellatus ADE45141 EO-SP  AAQ02909 VS-C4 
 ADC52861 EO-SP1  Q71QI2 VS-C2 
 ADE45139 EO-SP2  Q71QI0 VS-KNH7 
 ADE45140 EO-SP3  Q71QJ0 VS-KN2 
 CAQ72889 EO-SP4  Q71QJ2 VS-KN6 
 ADI47555 EO-SP5  Q71QH9 VS-KN14 
Echis pyramidum leakeyi ADI47558 EP-SP1 Vipera nikolskii CBW30778 VN-NI 
 
Table 2: VVSPs with substitutions for cysteine residues involved in the formation of disulphide linkages. The VVSPs and their substituted residue (blue) in the 
appropriate positions are shown in table. The positions of two corresponding cysteine residues which form disulphide linkage are placed next to each other to indicate 
the missing disulphide linkage due to substitution. VVSPs normally contain 6 disulphide linkages; C22-C157, C42-C58, C91-C245e, C136-C201, C168-C182 and C191-
C220. X indicates the substituted residue and – indicates a deletion.    
Name of VVSP 22 157 42 58 91 245e 136 201 168 182 191 220 
BAI-BH C C C C X C C C C C C C 
CAd-SP5 C C C C C X C C C C C C 
CC-CR C C X C C C C C C C C C 
DA-DK C C C C C C C X C C C C 
DA-TL4 C C C X C C C C C C C C 
DA-TL7 C C C C C C C X C C C C 
EO-SP2 C C C C C X C C C C C C 
EO-SP5 C C C C C - C C C C C C 
EO-SP6 C C C C C X C C C C C C 
GBB-SL C C C C X C C C C C C C 
VS-KN5 C C X C C C C C C C C C 
VS-KN6 C C X C C C C C C C C C 
VS-KN14 C C X C C C C C C C C C 
 
Table 3: VVSPs with substituted catalytic triad residues. VVSPs with various substitutions (blue) for their catalytic triad residues are shown in table. Normally VVSPs 
contain H57, D102 and S195 in their catalytic triad.  
Name of VVSP 57 102 195 Name of VVSP 57 102 195 
BGSP1 R D N ML-P2 R D N 
BG-RHIN2 R D N ML-P3 H D N 
BG-RHIN3 R D N ML-P4 R D S 
BAI-BH N T S TF-SP2 R D S 
Bas-SPL N D S TG-SP2A R D S 
BJa-HP3 Q D S TJ-SP1 R D P 
BJu-SPH N D S TJ-SPH R D S 
CAd-SP6 H D A VS-SPH1 R D S 
EC-SP4 R D T VS-KNH4 R D S 
EC-SP5 R D T VS-KNH7 R D S 
EO-SP R D T     
 
Table 4: VVSPs with substituted primary specificity pocket residues. VVSPs with various substitutions (blue) for their specificity pocket residues are shown in table. 
Normally VVSPs contain D189, G216 and G/A226 in their specificity pocket.  
Name of VVSP 189 216 226 Name of VVSP 189 216 226 
AP-PA D R G DA-TL12 G G G 
BG-SP1 D E A DR-SA G G S 
BG-RHIN2 D E A DR-SB G G V 
BG-RHIN3 D E A EC-SP6 G G G 
BG-RHIN4 G A G EC-SP7 G V G 
BG-RHIN5 G A G EP-SP1 G G V 
BJa-HP3 D R G EP-SP2 G G V 
CAd-SP3 G G G EO-SP1 G V G 
CR-ALP2 S G A EO-SP2 G S G 
CDD-SP G G E ML-AF G G G 
DA-AC G G G ML-BF G G V 
DA-AC2 G G G SCE-SP9 S G S 
DA-TL5 G G G SCE-SP5 S G G 
DA-TL6 G G G TF-SP3 G G G 
DA-TL7 G G G TG-SP3 D G N 
DA-TL8 G G G VS-C2 G T A 
DA-TL10 G G G VS-KN8 D G V 
DA-TL11 G G G     
 
 
